Edition:
United Kingdom

Zafgen Inc (ZFGN.OQ)

ZFGN.OQ on NASDAQ Stock Exchange Global Select Market

10.78USD
21 Sep 2018
Change (% chg)

$-0.17 (-1.55%)
Prev Close
$10.95
Open
$10.82
Day's High
$10.94
Day's Low
$10.29
Volume
737,266
Avg. Vol
116,518
52-wk High
$11.35
52-wk Low
$3.25

Chart for

About

Zafgen, Inc., is a clinical-stage biopharmaceutical company. The Company uses its proprietary methionine aminopeptidase 2 (MetAP2) biology platform to develop novel therapies for patients affected by complex metabolic diseases. Its product candidate is ZGN-1061 which is a novel fumagillin-class MetAP2 inhibitor that is used to... (more)

Overall

Beta: -1.40
Market Cap(Mil.): $94.27
Shares Outstanding(Mil.): 27.48
Dividend: --
Yield (%): --

Financials

  ZFGN.OQ Industry Sector
P/E (TTM): -- 85.68 32.76
EPS (TTM): -1.88 -- --
ROI: -42.22 1.79 14.61
ROE: -42.56 3.28 16.33

BRIEF-Zafgen Reports Q1 Loss Per Share $0.58

* ZAFGEN REPORTS FIRST QUARTER 2018 OPERATING AND FINANCIAL RESULTS

08 May 2018

Earnings vs. Estimates